secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0001213900-24-107941
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital Acquisition Corp. extends combination deadline to Jan 11, 2025; deposits $15,064
--------------------------------------------------------------------------------

- Deposited $15,063.74 into trust account to extend deadline from Dec 11, 2024 to Jan 11, 2025.
- Extension funded via convertible promissory note from Scilex Holding Company (Nasdaq: SCLX) for up to $180,000.
- Note bears no interest, repayable upon business combination or liquidation; convertible at $10.00/share into Class A ordinary shares.
- Remaining $104,708.30 principal available for future monthly extensions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024107941/0001213900-24-107941-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024107941/ea022443401-8k_denalicap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-107941

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer